{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:52:40Z","timestamp":1791118360129,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":593,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.jcmg.2011.08.014","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T20:50:08Z","timestamp":1323723008000},"page":"1239-1249","source":"Crossref","is-referenced-by-count":118,"title":["A Randomized Study of the Beneficial Effects of Aldosterone Antagonism on LV Function, Structure, and Fibrosis Markers in Metabolic Syndrome"],"prefix":"10.1016","volume":"4","author":[{"given":"Wojciech","family":"Kosmala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Przewlocka-Kosmala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Szczepanik-Osadnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Mysiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"O'Moore-Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Marwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2011.08.014_bib1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/j.amjcard.2005.07.091","article-title":"Myocardial and vascular dysfunction and exercise capacity in the metabolic syndrome","volume":"96","author":"Wong","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2011.08.014_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/eurheartj\/ehl526","article-title":"Metabolic syndrome is associated with abnormal left ventricular diastolic function independent of left ventricular mass","volume":"28","author":"de las Fuentes","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2011.08.014_bib3","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2008.04.013","article-title":"Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the Strong Heart study","volume":"52","author":"Chinali","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.08.014_bib4","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4065\/83.12.1350","article-title":"Abnormal cardiac structure and function in the metabolic syndrome: a population-based study","volume":"83","author":"Aijaz","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jcmg.2011.08.014_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/dmrr.1063","article-title":"The impact of metabolic syndrome on left ventricular myocardial performance","volume":"26","author":"Voulgari","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jcmg.2011.08.014_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jcmg.2011.08.014_bib7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.amjhyper.2007.01.023","article-title":"Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome","volume":"20","author":"Sciarretta","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jcmg.2011.08.014_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/147323000102900103","article-title":"Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy","volume":"29","author":"Sato","year":"2001","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jcmg.2011.08.014_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijcard.2005.02.016","article-title":"Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition","volume":"106","author":"van de Wal","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2011.08.014_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejheart.2004.04.013","article-title":"The clinical implications of aldosterone escape in congestive heart failure","volume":"6","author":"Struthers","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcmg.2011.08.014_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000081267","article-title":"Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy","volume":"73","author":"Wahed","year":"2005","journal-title":"Pharmacology"},{"key":"10.1016\/j.jcmg.2011.08.014_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FJC.0b013e318033dfd4","article-title":"Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation","volume":"49","author":"Nishioka","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jcmg.2011.08.014_bib13","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2011.08.014_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jcmg.2011.08.014_bib15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/01.CIR.0000138680.89536.A9","article-title":"Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure","volume":"110","author":"Mottram","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2011.08.014_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtcvs.2007.11.016","article-title":"Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery","volume":"136","author":"Tsukashita","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jcmg.2011.08.014_bib17","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1161\/CIRCULATIONAHA.105.571653","article-title":"Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study","volume":"112","author":"Izawa","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2011.08.014_bib18","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2011.08.014_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcmg.2008.11.011","article-title":"Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling","volume":"2","author":"van den Borne","year":"2009","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2011.08.014_bib20","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES)","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2011.08.014_bib21","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/CIRCULATIONAHA.108.809194","volume":"119","author":"Iraqi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2011.08.014_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcmg.2011.08.014_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0008-6363(97)00072-2","article-title":"Monitoring fibrillar collagen turnover in hypertensive heart disease","volume":"35","author":"D\u00edez","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jcmg.2011.08.014_bib24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.CIR.91.5.1450","article-title":"Increased serum concentrations of procollagen peptides in essential hypertension","volume":"91","author":"D\u00edez","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2011.08.014_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.CIR.104.3.286","article-title":"Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients","volume":"104","author":"L\u00f3pez","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2011.08.014_bib26","doi-asserted-by":"crossref","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"7","author":"Schulz","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.jcmg.2011.08.014_bib27","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2011.08.014_bib28","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.jcmg.2011.08.014_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2011.08.014_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/01.CIR.81.1.58","article-title":"In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans","volume":"81","author":"Picano","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2011.08.014_bib31","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/CS20030211","article-title":"Ventricular dysfunction in early diabetic heart disease: detection, mechanisms and significance","volume":"105","author":"Watts","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jcmg.2011.08.014_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0008-6363(00)00092-4","article-title":"Renin-angiotensin-aldosterone system and myocardial fibrosis","volume":"47","author":"Brilla","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jcmg.2011.08.014_bib33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.HYP.36.4.517","article-title":"Transforming growth factor beta in hypertensives with cardiorenal damage","volume":"36","author":"Laviades","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.jcmg.2011.08.014_bib34","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.HYP.26.6.971","article-title":"Biological determinants of aldosterone-induced cardiac fibrosis in rats","volume":"26","author":"Robert","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.jcmg.2011.08.014_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.24.1.30","article-title":"Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension","volume":"24","author":"Robert","year":"1994","journal-title":"Hypertension"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X11006966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X11006966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T16:57:05Z","timestamp":1561049825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X11006966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1936878X11006966"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2011.08.014","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}